LYPHF
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Aug 5 closing price
SCLX
Price
$0.68
Change
-$0.06 (-8.11%)
Updated
Nov 14 closing price
Ad is loading...

LYPHF vs SCLX

Header iconLYPHF vs SCLX Comparison
Open Charts LYPHF vs SCLXBanner chart's image
Luye Pharma Group
Price$0.31
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
Scilex Holding
Price$0.68
Change-$0.06 (-8.11%)
Volume$3.17M
CapitalizationN/A
LYPHF vs SCLX Comparison Chart
Loading...
SCLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
LYPHF vs. SCLX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYPHF is a Hold and SCLX is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (LYPHF: $0.31 vs. SCLX: $0.68)
Brand notoriety: LYPHF and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LYPHF: 100% vs. SCLX: 154%
Market capitalization -- LYPHF: $1.76B vs. SCLX: $165.55M
LYPHF [@Pharmaceuticals: Major] is valued at $1.76B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYPHF’s FA Score shows that 0 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • LYPHF’s FA Score: 0 green, 5 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, LYPHF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCLX’s TA Score shows that 5 TA indicator(s) are bullish.

  • SCLX’s TA Score: 5 bullish, 5 bearish.

Price Growth

LYPHF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -30.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.26%. For the same industry, the average monthly price growth was -5.33%, and the average quarterly price growth was +2.99%.

Reported Earning Dates

SCLX is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-4.26% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYPHF($1.76B) has a higher market cap than SCLX($166M). LYPHF YTD gains are higher at: -27.744 vs. SCLX (-66.667). LYPHF has higher annual earnings (EBITDA): 907M vs. SCLX (-109.1M). LYPHF has more cash in the bank: 5.51B vs. SCLX (3.92M). SCLX has less debt than LYPHF: SCLX (128M) vs LYPHF (9.49B). LYPHF has higher revenues than SCLX: LYPHF (5.2B) vs SCLX (46.7M).
LYPHFSCLXLYPHF / SCLX
Capitalization1.76B166M1,058%
EBITDA907M-109.1M-831%
Gain YTD-27.744-66.66742%
P/E Ratio19.23N/A-
Revenue5.2B46.7M11,135%
Total Cash5.51B3.92M140,525%
Total Debt9.49B128M7,415%
TECHNICAL ANALYSIS
Technical Analysis
SCLX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
47%
Momentum
ODDS (%)
Bearish Trend 1 day ago
42%
MACD
ODDS (%)
Bearish Trend 1 day ago
40%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
0%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
62%
Aroon
ODDS (%)
Bullish Trend 1 day ago
21%
View a ticker or compare two or three
Ad is loading...
SCLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

LYPHF and

Correlation & Price change

A.I.dvisor tells us that LYPHF and MRK have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and MRK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYPHF
1D Price
Change %
LYPHF100%
N/A
MRK - LYPHF
20%
Poorly correlated
-0.14%
OGN - LYPHF
13%
Poorly correlated
-1.92%
SNYNF - LYPHF
2%
Poorly correlated
-4.17%
SCLX - LYPHF
2%
Poorly correlated
-8.11%
CSWYF - LYPHF
1%
Poorly correlated
N/A
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and CSWYF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and CSWYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-8.11%
CSWYF - SCLX
24%
Poorly correlated
N/A
GRFS - SCLX
10%
Poorly correlated
+5.06%
MIRA - SCLX
7%
Poorly correlated
-3.85%
PFE - SCLX
5%
Poorly correlated
-2.62%
OGN - SCLX
5%
Poorly correlated
-1.92%
More